Header cover image

Pharmaceuticals & Biotech Consumer Discretionary

Results

1272

0 new

All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.

1,272 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

PBYI

Puma Biotechnology
US$2.581.2%0.8%US$126.5mUS$4.33PE14.5xE-46.4%n/a

KNTE

Kinnate Biopharma
US$2.65-0.4%-56.8%US$125.1mUS$2.30PB0.8xE14.6%n/a

CRVO

CervoMed
US$15.13-3.0%213.0%US$124.9mUS$53.00PS12.9xE-43.1%n/a

DBTX

Decibel Therapeutics
US$4.910%65.9%US$124.3mn/aPB2.3xn/an/a

PDSB

PDS Biotechnology
US$3.377.3%-28.3%US$124.1mUS$12.40PB4xE9.7%n/a

SCLX

Scilex Holding
US$0.9419.6%-29.3%US$123.9mUS$5.50PS2.4xE30.8%n/a

ACTU

Actuate Therapeutics
US$6.27-5.9%n/aUS$122.5mn/aPE-4.2xn/an/a

CHRS

Coherus BioSciences
US$1.051.0%-70.8%US$121.0mUS$7.25PE-4.1xE55.4%n/a

SEER

Seer
US$1.9611.7%-11.9%US$120.1mUS$3.00PS8.1xE9.8%n/a

HBIO

Harvard Bioscience
US$2.723.0%-36.2%US$118.6mUS$6.25PS1.2xE83.0%n/a

DERM

Journey Medical
US$5.7210.9%108.0%US$118.6mUS$9.13PE140.6xE26.1%n/a

ACET

Adicet Bio
US$1.430%9.2%US$117.8mUS$6.25PB0.5xE8.3%n/a

PRLD

Prelude Therapeutics
US$2.12-10.5%-23.3%US$116.7mUS$5.80PB0.6xE-8.2%n/a

RANI

Rani Therapeutics Holdings
US$2.16-0.9%4.9%US$115.4mUS$11.75PB22.3xE25.2%n/a

INMB

INmune Bio
US$5.221.2%-20.9%US$115.3mUS$19.80PS1357xE23.9%n/a

NVCT

Nuvectis Pharma
US$6.18-4.2%-47.5%US$115.3mUS$22.00PB9.2xE38.1%n/a

AGEN

Agenus
US$5.493.6%-73.9%US$114.5mUS$9.75PE-0.5xE-1.7%n/a

SKYE

Skye Bioscience
US$3.757.4%-4.6%US$113.8mUS$17.60PB1.6xE-26.8%n/a

ASRT

Assertio Holdings
US$1.18-3.3%-51.8%US$112.5mUS$3.15PB0.9xE106.6%n/a

FBLG

FibroBiologics
US$3.1915.6%n/aUS$112.5mUS$13.00PE-5.8xE-22.7%n/a

XFOR

X4 Pharmaceuticals
US$0.66-7.2%-33.8%US$110.4mUS$4.05PE6.3xE-8.0%n/a

CYTT

Cyteir Therapeutics
US$3.010.3%77.1%US$108.3mn/aPB0.9xn/an/a

VSTM

Verastem
US$2.69-1.8%-65.7%US$108.3mUS$11.71PS10.8xE27.0%n/a

CBST.F

Cannabist Company Holdings
US$0.232.4%-75.0%US$106.4mn/aPB4.5xE54.7%n/a
Page 20 of 53
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.